.jpg)
.jpg)
.jpg)
Roche looks to 'expand and upgrade' US research centers as part of $50B investment strategy in the country
Roche has pledged to upgrade three R&D sites and pointed to the recent announcement of a new home for its cardiovascular, renal and metabolism R&D work as proof that the Swiss pharma is investing serious money in the U.S.
Roche has pledged to upgrade three R&D sites and pointed to the recent announcement of a new home for its cardiovascular, renal and metabolism R&D work as proof that the Swiss pharma is investing serious money in the U.S.
